Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

Fig. 2

Efficacy: PCR-adjusted ACPR28 in the PP population, a by region (all ages), b by age in African patients, percentage in each category with 95% confidence intervals. The numbers presented above the bars are the percent ACPR28. The majority of treatment failures were late parasitological failures (32.9% across the populations and treatment arms), with one early treatment failure in an African patient > 5 years (PQP 640 mg arm)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us